Sign in
4

Changes in Ownership

Cue Biopharma, Inc. Filed Acc 0000950170-24-028608

Options or other derivatives

  • Chief Medical Officer acquired 260,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Levisetti Matteo Chief Medical Officer 2024-03-06 Grant or award · Stock Option (right to buy) +260,000 260,000 D
Loading xslF345X05/ownership.xml…